(3.237.2.4)
Users online: 2982    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2018, Volume : 11, Issue : 10
First page : ( 4487) Last page : ( 4491)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2018.00821.1

Development and validation of a new stability indicating ultrafast liquid chromatographic method for the determination of Exemestane tablets

Bindu Gujju Hima*, Annapurna Mukthinuthalapati Mathrusri

Department of Pharmaceutical Analysis & Quality Assurance, GITAM Institute of Pharmacy, GITAM (Deemed to be University, Visakhapatnam-530045, India

*Corresponding Author E-mail: bindureddy.frnd@gmail.com

Online published on 20 December, 2018.

Abstract

Exemestane is an irreversible steroidal aromatase inactivator. Exemestane is used for postmenopausal women who are suffering with estrogen receptor positive early breast cancer as an adjuvant treatment. A new stability indicating ultrafast liquid chromatographic method was developed and validated for the determination of Exemestane. Shimadzu Model UFLC system with PDA detector was used for the present study. Mobile phase consisting of tetra butyl ammonium hydrogen sulphate and acetonitrile (30: 70, v/v) was used with a flow rate of 1.2 mL/min (Detection wavelength 250 nm). Exemestane shows linearity 0.5–100 μg/mL with linear regression equation y = 62584 x + 599.1 (R2 = 0.9999). The LOD and LOQ were found to be 0.1401 and 0.4348 μg/mL. Stress degradation studies were performed and method was validated as per ICH guidelines.

Top

Keywords

UFLC, Exemestane, Validation, Stability-indicating, ICH guidelines.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
515,401,864 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.